« back to the search result list  
PERFLUOROISOBUTYLENEICSC: 1216 (April 2004)
Octafluoroisobutylene
1,1,3,3,3-Pentafluoro-2-trifluoromethyl-1-propene
Octafluoro-sec-butene
CAS #: 382-21-8

  ACUTE HAZARDS PREVENTION FIRE FIGHTING
FIRE & EXPLOSION         In case of fire in the surroundings, use appropriate extinguishing media.   

 STRICT HYGIENE!  
  SYMPTOMS PREVENTION FIRST AID
Inhalation Sore throat. Cough. Nausea. Headache. Weakness. Shortness of breath. Laboured breathing. Symptoms may be delayed. See Notes.  Use ventilation, local exhaust or breathing protection.  Fresh air, rest. Half-upright position. Artificial respiration may be needed. Refer for medical attention. 
Skin   Protective gloves.   
Eyes   Wear safety spectacles.  First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention. 
Ingestion      

SPILLAGE DISPOSAL CLASSIFICATION & LABELLING
Evacuate danger area! Consult an expert! Ventilation. Personal protection: self-contained breathing apparatus. 

According to UN GHS Criteria

 

Transportation
UN Classification
 

STORAGE
 
PACKAGING
 
PERFLUOROISOBUTYLENE ICSC: 1216
PHYSICAL & CHEMICAL INFORMATION

Physical State; Appearance
COLOURLESS GAS. 

Physical dangers
 

Chemical dangers
 

Formula: C4F8
Molecular mass: 200.0
Boiling point: 7°C
Density: 1.6 g/l 


EXPOSURE & HEALTH EFFECTS

Routes of exposure
The substance can be absorbed into the body by inhalation. 

Effects of short-term exposure
The substance is irritating to the respiratory tract. Inhalation of this gas may cause lung oedema. See Notes. Exposure could cause death. The effects may be delayed. Medical observation is indicated. 

Inhalation risk
A harmful concentration of this gas in the air will be reached very quickly on loss of containment. 

Effects of long-term or repeated exposure
 


OCCUPATIONAL EXPOSURE LIMITS
TLV: 0.01 ppm as STEL 

ENVIRONMENT
 

NOTES
This substance is formed as a by-product in tetrafluoroethylene production and during thermal degradation of polytetrafluoroethylene (PTFE/Teflon(R)) at approximately 425°C.
The occupational exposure limit value should not be exceeded during any part of the working exposure.
The symptoms of lung oedema often do not become manifest until a few hours have passed and they are aggravated by physical effort.
Rest and medical observation are therefore essential.
Immediate administration of an appropriate inhalation therapy by a doctor, or by an authorized person, should be considered. 

ADDITIONAL INFORMATION
  EC Classification
 

All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material.